Entrada Therapeutics, Inc. insider trading activity

Understanding Insider Activity at Entrada Therapeutics, Inc.

Welcome to our dedicated page for Entrada Therapeutics, Inc. (Nasdaq: TRDA) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Entrada Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Entrada Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for TRDA
TickerTime & DateFilingLink
TRDA9:49:06 PM 11/13/2024
Sethuraman Natarajan(President, Research & Develop.) sold 4109 shares of Entrada Therapeutics, Inc. (TRDA) for ~$82302
Filing
TRDA9:47:06 PM 11/13/2024
WENTWORTH KORY JAMES(Chief Financial Officer) sold 8637 shares of Entrada Therapeutics, Inc. (TRDA) for ~$172567
Filing
TRDA9:36:50 PM 11/6/2024
Sethuraman Natarajan(President, Research & Develop.) sold 18219 shares of Entrada Therapeutics, Inc. (TRDA) for ~$339292
Filing
TRDA8:31:39 PM 10/18/2024
Sethuraman Natarajan(President, Research & Develop.) sold 600 shares of Entrada Therapeutics, Inc. (TRDA) for ~$10800
Filing
TRDA8:32:11 PM 9/30/2024
Dowden Nathan J(President & COO) sold 847 shares of Entrada Therapeutics, Inc. (TRDA) for ~$13552
Filing
TRDA8:34:51 PM 9/10/2024
WENTWORTH KORY JAMES(Chief Financial Officer) sold 3195 shares of Entrada Therapeutics, Inc. (TRDA) for ~$47829
Filing
TRDA8:33:34 PM 9/10/2024
Dowden Nathan J(President & COO) sold 2303 shares of Entrada Therapeutics, Inc. (TRDA) for ~$34753
Filing
TRDA8:32:12 PM 9/10/2024
Sethuraman Natarajan(Chief Scientific Officer) sold 3242 shares of Entrada Therapeutics, Inc. (TRDA) for ~$49011
Filing
TRDA8:33:43 PM 8/20/2024
Dowden Nathan J(President & COO) sold 27097 shares of Entrada Therapeutics, Inc. (TRDA) for ~$440817
Filing
TRDA8:43:46 PM 7/16/2024
Sethuraman Natarajan(Chief Scientific Officer) sold 1238 shares of Entrada Therapeutics, Inc. (TRDA) for ~$22284
Filing
TRDA8:42:17 PM 7/16/2024
Doshi Dipal(CEO) sold 1900 shares of Entrada Therapeutics, Inc. (TRDA) for ~$33896
Filing
TRDA8:34:42 PM 7/10/2024
WENTWORTH KORY JAMES(Chief Financial Officer) sold 1758 shares of Entrada Therapeutics, Inc. (TRDA) for ~$26282
Filing
TRDA8:32:12 PM 6/14/2024
Doshi Dipal(CEO) sold 1000 shares of Entrada Therapeutics, Inc. (TRDA) for ~$16170
Filing
TRDA9:26:05 PM 5/20/2024
Sethuraman Natarajan(Chief Scientific Officer) sold 18980 shares of Entrada Therapeutics, Inc. (TRDA) for ~$287700
Filing
TRDA9:21:58 PM 5/20/2024
Doshi Dipal(CEO) sold 3000 shares of Entrada Therapeutics, Inc. (TRDA) for ~$45132
Filing
TRDA8:33:48 PM, 5/16/2024
KIM PETER S purchased 25000 shares of Entrada Therapeutics, Inc. (TRDA) for ~$364750
Filing
TRDA12:00:01 AM, 5/10/2024
KIM PETER S purchased 4476 shares of Entrada Therapeutics, Inc. (TRDA) for ~$63305
Filing
TRDA8:35:18 PM, 4/10/2024
KIM PETER S purchased 2600 shares of Entrada Therapeutics, Inc. (TRDA) for ~$35282
Filing
TRDA8:31:27 PM, 4/1/2024
KIM PETER S purchased 1512 shares of Entrada Therapeutics, Inc. (TRDA) for ~$20790
Filing
TRDA9:57:20 PM, 3/26/2024
KIM PETER S purchased 9048 shares of Entrada Therapeutics, Inc. (TRDA) for ~$122897
Filing
TRDA8:31:20 PM, 3/21/2024
KIM PETER S purchased 2732 shares of Entrada Therapeutics, Inc. (TRDA) for ~$34994
Filing
TRDA9:36:21 PM 3/8/2024
WENTWORTH KORY JAMES(Chief Financial Officer) sold 4086 shares of Entrada Therapeutics, Inc. (TRDA) for ~$50298
Filing
TRDA9:34:26 PM 3/8/2024
Dowden Nathan J(President & COO) sold 1826 shares of Entrada Therapeutics, Inc. (TRDA) for ~$22496
Filing
TRDA9:37:38 PM 2/20/2024
Doshi Dipal(CEO) sold 1000 shares of Entrada Therapeutics, Inc. (TRDA) for ~$15000
Filing
TRDA9:32:35 PM 1/18/2024
Doshi Dipal(CEO) sold 1000 shares of Entrada Therapeutics, Inc. (TRDA) for ~$15990
Filing

Discover the Complete Picture 🔒

Currently viewing just 6 of 61 insider filings.
Register now to dive deeper and explore the full dataset.